Oric Pharmaceuticals director proposes $109K sale

The prior-three-month sales table also records transactions by Richard Heyman and RAHD Capital, LLC, including sales of 6,850 and 6,250 shares.

Rhea-AI Filing Summary

Oric Pharmaceuticals, Inc. director Richard A. Heyman filed a notice covering the proposed sale of 8,100 common shares, with an aggregate market value of $109,107. J.P. Morgan Securities LLC is named in the broker field. The notice says some sales are from cashless option exercises that will occur within three months of October 1, 2026.

Key Figures

Common shares proposed for sale: 8,100 shares Aggregate market value: $109,107 Prior sale by Richard Heyman: 6,850 shares +3 more

6 metrics

Common shares proposed for sale 8,100 shares Notice of proposed sale

Aggregate market value $109,107 Shares proposed for sale

Prior sale by Richard Heyman 6,850 shares July 24, 2026

Prior sale by RAHD Capital, LLC 6,250 shares July 24, 2026

Prior sale by Richard Heyman 150 shares July 6, 2026

Prior sale by RAHD Capital, LLC 150 shares July 6, 2026

Key Terms

Rule 144, Cashless Option Exercises, attorney-in-fact

3 terms

Rule 144 regulatory

"the definition of “person” in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Cashless Option Exercises financial

"Some of the sales under this filing are from Cashless Option Exercises"

attorney-in-fact technical

"as agent and attorney-in-fact for Richard A. Heyman"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares does ORIC director Richard A. Heyman plan to sell?

The notice covers the proposed sale of 8,100 common shares, with an aggregate market value of $109,107.

When will the cashless option exercises in the ORIC notice occur?

The notice says some sales are from cashless option exercises that will occur within three months of October 1, 2026.

What prior sales are listed for Richard Heyman and RAHD Capital, LLC?

The prior-three-month table lists Richard Heyman sales of 150 shares on July 6, 2026 and 6,850 shares on July 24, 2026. It lists RAHD Capital, LLC sales of 150 shares on July 6, 2026 and 6,250 shares on July 24, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 04:24 PM Accepted by SEC EDGAR 10/01/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001584759
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Oric Pharmaceuticals, Inc.
SEC File Number	001-39269
Address of Issuer	240 E. Grand Ave 2nd Floor San Francisco CALIFORNIA 94080
Phone	6503885600
Name of Person for Whose Account the Securities are To Be Sold	Richard A, Heyman
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Avenue 10th Floor New York NY 10017	8100	109107	103652656	10/01/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2016	Stock Option Exercise	Issuer			4600	08/25/2016	Cash
Common	10/01/2026	Stock Option Exercise	Issuer			3500	10/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard Heyman 240 E. GRAND AVE. 2ND Floor SOUTH SAN FRANCISCO CA 94080	Common	07/06/2026	150	1800
Richard Heyman 240 E. GRAND AVE. 2ND Floor SOUTH SAN FRANCISCO CA 94080	Common	07/24/2026	6850	82340
RAHD Capital, LLC 240 E. GRAND AVE. 2ND Floor SOUTH SAN FRANCISCO CA 94080	Common	07/06/2026	150	1800
RAHD Capital, LLC 240 E. GRAND AVE. 2ND Floor SOUTH SAN FRANCISCO CA 94080	Common	07/24/2026	6250	75128

144: Remarks and Signature

Remarks	Some of the sales under this filing are from Cashless Option Exercises that will occur within 3 months from the date of this filing.
Date of Notice	10/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Richard A. Heyman.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)